Exercise stress echocardiography for detection of pulmonary arterial hypertension in a patient with systemic sclerosis;Ecocardiografia de esforço na detecção de hipertensão arterial pulmonar numa doente com esclerodermia

Revista Portuguesa de Cardiologia

Volumn 25, Issue 2, 2006, Pages 199-203

  Cotrim, Carlos ^a,b   Cordeiro, Ana ^a   Loureiro, Maria José ^a   Santos, Maria José ^a   Simões, Otília ^a   Cordeiro, Pedro ^a   Da Silva, J Canas ^a   Carrageta, Manuel ^a  

^a HOSPITAL GARCIA DE ORTA   (Portugal)

^b NONE   (Portugal)

Author keywords

Echocardiography; Exercise stress echocardiography; Pulmonary arterial hypertension; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DIAGNOSTIC VALUE; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; EXERCISE; FATIGUE; FEMALE; HEART CATHETERIZATION; HUMAN; OUTPATIENT; PULMONARY HYPERTENSION; STRESS ECHOCARDIOGRAPHY; SYSTEMIC SCLEROSIS;

ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

EID: 33645720371     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Sanchez O, Humbert M, Simonneau G et al. Hypertension artérielle pulmonaire associée aux connectivites. Rev Med Interne 2002;23:41-54.
2. Ungerer RG, Tashkin DP, Furst D et al. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 1983;75:65-74.
3. Badesch DB, Tapson VF, McGoon MD, et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial. Ann Inter Med 2000;132:425-434.
4. Mok MY, Tse HF, Lau CS, et al. Pulmonary hypertension secondary to systemic lupus erythematosus: prolonged survival following treatment with intermittent low dose iloprost. Lupus 1999;8:328-331.
5. Oudiz RJ, Schilz RJ, Barst RJ, et al. Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease. Chest 2004;126:420-427.
6. Mayes MD. Endothelin and endothelin receptor antagonists in systemic rheumatic disease. Arthritis & Rheumatism 2003;48:1190-1199.
7. Watanabe H, Ohashi K, Takeuchi K, et al. Sildenafil for primary and secondary pulmonary hypertension. Clin Pharmacol Ther 2002;71:398-402.
8. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:40S-47S.
9. McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension. Chest 2004;126:14S-34S.
10. Cotrim C, Carrageta M. Ecocardiografia de Sobrecarga - Esforço. Rev Port Cardiol 2000;19 (3):345-350.
11. Galié N, Torbicki A, Barst R et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. European Heart Journal 2004;25:2243-2278.
12. Hachula E, Coghlan JG. A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism. Ann Rheum Dis 2004;63:1009-1014.
13. Rich S, Rubin LJ, Abenhail L, et al. Executive summary from the World Symposium on Primary Pulmonary Hypertension (Evian, France, September 6-10, 1998) World Health Organization publication via the internet. Available online at: http://www.who.int/ncd/cvd/pph.htrnl.
14. Mukerjee D, St. George D, Knight C, et al. Echocardiography and pulmonary function as screening test for pulmonary arterial hypertension in systemic sclerosis. Rheumatology 2004;43:461-466.
15. Franz IW, Van Der Meyden J, Schaup S, et al. The effect of amlodipine on exercise-induced pulmonary hypertension and right heart function in patients with chronic obstructive pulmonary disease. Z Kardiol 2002;91:833-839.